The Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the global drug delivery devices market has seen significant growth lately. The market, which was valued at $91.03 billion in 2024, is projected to expand to $96.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.3%.
The Drug Delivery Devices Global Market Report 2025 predicts that by 2029, the market will grow to $124.82 billion. This represents a compound annual growth rate (CAGR) of 6.6%.
Download Your Free Sample of the 2025 Drug Delivery Devices Market Report and Uncover Key Trends Now!The key drivers in the drug delivery devices market are:
• Rising prevalence of chronic diseases
• Growing demand for injectables
• Increasing interest in microneedle drug technology
• Investments in research and development of self-injectable drug delivery devices
The drug delivery devices market covered in this report is segmented –
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications
The key trends in the drug delivery devices market are:
• The industry sees a rising trend in the development of microneedle drug technology for drug delivery.
• Development and research into self-injectable drug delivery devices are noticeable trends.
• There is an increasing concentration on mergers and acquisitions in this market.
• Investments in wearable drug delivery devices are marking a significant emerging trend.
Major companies in the drug delivery devices market are:
• Becton, Dickinson and Company
• Baxter International
• B. Braun Melsungen AG
• Catalent
• 3M Company
• West Pharmaceutical Services, Inc.
• Gerresheimer AG
• Smiths Medical
• Boehringer Ingelheim
• SMC Ltd.
• Elcam Medical
• Eli Lilly and Company
• Injex
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc
• Sanofi Sa
• Schott AG
• Terumo Corporation
• Teva Pharmaceuticals
• Ypsomed Holding AG
• F. Hoffmann-La Roche AG
• GlaxoSmithKline
• AstraZeneca
• Congenica Ltd.
• UCB
• Alkermes
• Aptalis Pharma, Inc.
• Johnson & Johnson
• Nektar Therapeutics
• SkyePharma PLC
• Pharmasyntez
• NEARMEDIC PLUS LLC
• Copernicus
• Medtronic
• Philips
• Siemens
• Stryker
• GE Healthcare
• Teleflex Medical
• Gilero
• Kedalion Therapeutics
• MediPrint Ophthalmics
• Nemera
• Pendant Biosciences
• Battelle Medical Devices
• Merck & Co. Inc.
• Antares Pharma
• Abbot
• Allergan
• Bilim Pharmaceuticals
• H&T Presspart
• Hovione Technology
• Sorrel Medical
• Syqe Medical
• Julphar
• ResMed Inc
• Covidien plc
North America was the largest region in the drug delivery devices market in 2024